Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Argus Health
Boehringer Ingelheim
Chinese Patent Office
Teva
Novartis
Mallinckrodt
McKinsey
Dow
Cantor Fitzgerald

Generated: October 17, 2017

DrugPatentWatch Database Preview

APRESOLINE Drug Profile

« Back to Dashboard

Which patents cover Apresoline, and when can generic versions of Apresoline launch?

Apresoline is a drug marketed by Novartis and is included in two NDAs.

The generic ingredient in APRESOLINE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.

Summary for Tradename: APRESOLINE

US Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list105
Clinical Trials: see list3
Patent Applications: see list868
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:APRESOLINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
APRESOLINE
hydralazine hydrochloride
INJECTABLE;INJECTION008303-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis
APRESOLINE
hydralazine hydrochloride
TABLET;ORAL008303-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis
APRESOLINE
hydralazine hydrochloride
TABLET;ORAL008303-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis
APRESOLINE
hydralazine hydrochloride
TABLET;ORAL008303-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis
APRESOLINE-ESIDRIX
hydralazine hydrochloride; hydrochlorothiazide
TABLET;ORAL012026-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
APRESOLINE
hydralazine hydrochloride
TABLET;ORAL008303-005Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Johnson and Johnson
Teva
Harvard Business School
Express Scripts
US Army
Chinese Patent Office
Julphar
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot